Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-31 2024-12-31 true true true true true 2024-01-01 false 53 The principal activity of the cpmpany continued to be that of the manufacturing of fibreglass products.55 true true false 04064725 2024-01-01 2024-12-31 04064725 2023-01-01 2023-12-31 04064725 2024-12-31 04064725 2023-12-31 04064725 1 2024-01-01 2024-12-31 04064725 d:Director1 2024-01-01 2024-12-31 04064725 c:Buildings c:LongLeaseholdAssets 2024-01-01 2024-12-31 04064725 c:Buildings c:LongLeaseholdAssets 2024-12-31 04064725 c:Buildings c:LongLeaseholdAssets 2023-12-31 04064725 c:PlantMachinery 2024-01-01 2024-12-31 04064725 c:PlantMachinery 2024-12-31 04064725 c:PlantMachinery 2023-12-31 04064725 c:PlantMachinery c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04064725 c:MotorVehicles 2024-01-01 2024-12-31 04064725 c:MotorVehicles 2024-12-31 04064725 c:MotorVehicles 2023-12-31 04064725 c:MotorVehicles c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04064725 c:FurnitureFittings 2024-01-01 2024-12-31 04064725 c:FurnitureFittings 2024-12-31 04064725 c:FurnitureFittings 2023-12-31 04064725 c:FurnitureFittings c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04064725 c:ComputerEquipment 2024-01-01 2024-12-31 04064725 c:ComputerEquipment 2024-12-31 04064725 c:ComputerEquipment 2023-12-31 04064725 c:ComputerEquipment c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04064725 c:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04064725 c:CopyrightsPatentsTrademarksServiceOperatingRights 2024-01-01 2024-12-31 04064725 c:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-31 04064725 c:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-31 04064725 c:CurrentFinancialInstruments 2024-12-31 04064725 c:CurrentFinancialInstruments 2023-12-31 04064725 c:CurrentFinancialInstruments 1 2024-12-31 04064725 c:CurrentFinancialInstruments 1 2023-12-31 04064725 c:Non-currentFinancialInstruments 2024-12-31 04064725 c:Non-currentFinancialInstruments 2023-12-31 04064725 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 04064725 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-31 04064725 c:ShareCapital 2024-12-31 04064725 c:ShareCapital 2023-12-31 04064725 c:SharePremium 2024-12-31 04064725 c:SharePremium 2023-12-31 04064725 c:RetainedEarningsAccumulatedLosses 2024-12-31 04064725 c:RetainedEarningsAccumulatedLosses 2023-12-31 04064725 c:AcceleratedTaxDepreciationDeferredTax 2024-12-31 04064725 c:AcceleratedTaxDepreciationDeferredTax 2023-12-31 04064725 c:RetirementBenefitObligationsDeferredTax 2024-12-31 04064725 c:RetirementBenefitObligationsDeferredTax 2023-12-31 04064725 c:OtherDeferredTax 2024-12-31 04064725 c:OtherDeferredTax 2023-12-31 04064725 d:FRS102 2024-01-01 2024-12-31 04064725 d:Audited 2024-01-01 2024-12-31 04064725 d:FullAccounts 2024-01-01 2024-12-31 04064725 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04064725 d:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04064725 2 2024-01-01 2024-12-31 04064725 4 2024-01-01 2024-12-31 04064725 c:CopyrightsPatentsTrademarksServiceOperatingRights c:OwnedIntangibleAssets 2024-01-01 2024-12-31 04064725 f:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 04064725 SUI GENERIS INTERNATIONAL LIMITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 DECEMBER 2024
SUI GENERIS INTERNATIONAL LIMITED REGISTERED NUMBER: 04064725 STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2024
|  | 2024 |  | Unaudited 2023
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Intangible assets | 4 |  | 135 |  | 152
Tangible assets | 5 |  | 397,387 |  | 391,963
|  |  | 397,522 |  | 392,115
Current assets |  |  |  |  |
Stocks | 6 | 507,827 |  | 731,722 |
Debtors | 7 | 3,126,358 |  | 2,916,126 |
Cash at bank and in hand | 8 | 276,287 |  | 10,597 |
|  | 3,910,472 |  | 3,658,445 |
Creditors: amounts falling due within one year | 9 | (1,973,850) |  | (1,237,268) |
Net current assets |  |  | 1,936,622 |  | 2,421,177
Total assets less current liabilities |  |  | 2,334,144 |  | 2,813,292
Provisions for liabilities |  |  |  |  |
Deferred tax | 10 | (30,888) |  | (34,533) |
|  |  | (30,888) |  | (34,533)
Net assets |  |  | 2,303,256 |  | 2,778,759
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 160,805 |  | 160,805
Share premium account |  |  | 12,784 |  | 12,784
Profit and loss account |  |  | 2,129,667 |  | 2,605,170
|  |  | 2,303,256 |  | 2,778,759
Page 1
SUI GENERIS INTERNATIONAL LIMITED REGISTERED NUMBER: 04064725 STATEMENT OF FINANCIAL POSITION (CONTINUED) AS AT 31 DECEMBER 2024 The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
................................................ Mr S R Milbank
Director
Date: 17 September 2025
Page 2
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
1. | General information
Sui Generis International Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lindsey House, Brunel Way, Severalls Industrial Park, Colchester, Essex, CO4 9QX. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies. The following principal accounting policies have been applied:
| 2.2 | Financial Reporting Standard 102 - reduced disclosure exemptions
The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland": ∙the requirements of Section 7 Statement of Cash Flows; ∙the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d); ∙the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c); ∙the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A; ∙the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21 and 26.23; ∙the requirements of Section 33 Related Party Disclosures paragraph 33.7. This information is included in the consolidated financial statements of Milbank Ventures Limited as at 31 December 2024 and these financial statements may be obtained from Lindsey House, Brunel Way, Severalls Industrial Park, Colchester, Essex, CO4 9QX.
| 2.3 | Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements. Page 3
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.4 | Foreign currency translation
Functional and presentation currency The Company's functional and presentational currency is GBP. Transactions and balances Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges. Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.
| 2.5 | Operating leases: the Company as lessee
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.
| 2.6 | Research and development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years. If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.
| 2.7 | Interest income
Interest income is recognised in profit or loss using the effective interest method.
| 2.8 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument. Page 4
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.9 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Sale of goods Revenue from the sale of goods is recognised when all of the following conditions are satisfied: ∙the Company has transferred the significant risks and rewards of ownership to the buyer; ∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the transaction; and ∙the costs incurred or to be incurred in respect of the transaction can be measured reliably. Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 2.10 | Pensions
Defined contribution pension plan The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds. Page 5
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.11 | Current and deferred taxation
The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income. Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that: ∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and ∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met. Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.
| 2.12 | Exceptional items
Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.
| 2.13 | Intangible assets
Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years. The estimated useful lives range as follows:
|  |  |  | Trademarks | - | 10 | years
Page 6
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.14 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on the following bases:. Depreciation is provided on the following basis:
|  |  |  | Long-term leasehold property | - | 10% | Straight line
|  |  |  | Plant and machinery | - | 25% | Straight line
|  |  |  | Motor vehicles | - | 25% | Reducing balance
|  |  |  | Fixtures and fittings | - | 25% | Reducing balance
|  |  |  | Computer equipment | - | 20% | Straight line
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.15 | Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads. At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.
| 2.16 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. Page 7
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.17 | Financial instruments
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments. Basic financial assets Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments. Impairment of financial assets At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate. If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss. Financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities. Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial. Debt instruments are subsequently carried at their amortised cost using the effective interest rate method. Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment Page 8
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2.Accounting policies (continued)
| 2.17 | Financial instruments (continued)
is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial. Derecognition of financial instruments Derecognition of financial assets Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained. Derecognition of financial liabilities Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.
| 2.18 | Dividends
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
3. | Employees
| The average monthly number of employees, including directors, during the year was 53 (2023 - 55).
Page 9
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
4. | Intangible assets
|  | Trademarks
|  | £
| Cost |
| At 1 January 2024 | 170
| At 31 December 2024 | 170
| Amortisation |
| At 1 January 2024 | 18
| Charge for the year on owned assets | 17
| At 31 December 2024 | 35
| Net book value |
| At 31 December 2024 | 135
| At 31 December Unaudited 2023 | 152
Page 10
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
5. | Tangible fixed assets
|  | Long-term leasehold property | Plant and machinery | Motor vehicles | Fixtures and fittings | Computer equipment | Total
|  | £ | £ | £ | £ | £ | £
| Cost or valuation |  |  |  |  |  |
| At 1 January 2024 | 340,256 | 696,976 | 28,976 | 138,979 | 165,880 | 1,371,067
| Additions | - | 102,303 | - | 5,303 | 15,045 | 122,651
| Disposals | - | - | (11,586) | - | - | (11,586)
| At 31 December 2024 | 340,256 | 799,279 | 17,390 | 144,282 | 180,925 | 1,482,132
| Depreciation |  |  |  |  |  |
| At 1 January 2024 | 167,594 | 574,916 | 16,593 | 114,269 | 105,732 | 979,104
| Charge for the year on owned assets | 26,717 | 73,487 | 2,765 | 3,248 | 11,010 | 117,227
| Disposals | - | - | (11,586) | - | - | (11,586)
| At 31 December 2024 | 194,311 | 648,403 | 7,772 | 117,517 | 116,742 | 1,084,745
| Net book value |  |  |  |  |  |
| At 31 December 2024 | 145,945 | 150,876 | 9,618 | 26,765 | 64,183 | 397,387
| At 31 December Unaudited 2023 | 172,662 | 122,060 | 12,383 | 24,710 | 60,148 | 391,963
6. | Stocks
|  |  |  |  | 2024 | Unaudited 2023
|  |  |  |  | £ | £
| Raw materials and consumables | 311,687 | 411,636
| Work in progress (goods to be sold) | 49,981 | 41,795
| Finished goods and goods for resale | 146,159 | 278,291
|  | 507,827 | 731,722
Page 11
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
7. | Debtors
|  |  |  |  | 2024 | Unaudited 2023
|  |  |  |  | £ | £
| Due after more than one year |  |
| Amounts owed by group undertakings | 2,454,375 | 1,976,231
|  | 2,454,375 | 1,976,231
| Due within one year |  |
| Trade debtors | 222,577 | 624,026
| Amounts owed by group undertakings | 134,750 | -
| Other debtors | 314,656 | 315,869
|  | 3,126,358 | 2,916,126
8. | Cash and cash equivalents
|  |  |  |  | 2024 | Unaudited 2023
|  |  |  |  | £ | £
| Cash at bank and in hand | 276,287 | 10,597
|  | 276,287 | 10,597
Page 12
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
9. | Creditors: Amounts falling due within one year
|  |  |  |  | 2024 | Unaudited 2023
|  |  |  |  | £ | £
| Trade creditors | 436,418 | 283,765
| Amounts owed to group undertakings | 348,281 | 203,900
| Corporation tax | - | 54,895
| Other taxation and social security | 231,700 | 219,541
| Warranty provision | 298,000 | -
| Other creditors | 365,810 | 475,167
| Accruals and deferred income | 293,641 | -
|  | 1,973,850 | 1,237,268
| Included within Other creditors is an invoice financing facility of £164,422 (2023: £320,417) secured by a debenture on the book debts of the company. The warranty provision relates to contractual remedial obligations associated with installations in the year. This has been estimated on actual costs of installing similar products.
Page 13
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
10. | Deferred taxation
|  | 2024
|  | £
| At beginning of year | (34,533)
| Charged to profit or loss | 3,645
| At end of year | (30,888)
|  |  |  |  | 2024 | Unaudited 2023
|  |  |  |  | £ | £
| Accelerated capital allowances | (42,256) | (35,677)
| Pension contributions deductible on paid basis | 868 | 1,144
| Reserves | 10,500 | -
|  | (30,888) | (34,533)
11.Financial commitments, guarantees and contingent liabilities There is a Composite Guarantee and Debenture with Arbuthnot Commercial Asset Based Lending Limited dated 9th May 2022 under which the Company is party to a guarantee of the liabilities of certain fellow group companies under the terms of a Receivables Financing Agreement. The total amounts due by fellow group companies under this agreement is £2.0m. Each group company has net assets and the directors consider that they will comfortably meet their obligations as they fall due and the guarantee will have no impact on the Company. There is a Debenture with Lloyds Bank Plc dated 23 April 2019 under which there are fixed and floating charges, over all property and assets of the company, in relation to a loan made by Lloyds Bank Plc to a company under common ultimate control. At the year end the balance of this loan was £0.45m. the Company under common control has net assets and the Directors consider that they will comfortably meet their obligations as they fall due and the Debenture will have no impact on the Company.
12. | Post balance sheet events
Subsequent to the period end the Company entered into a debenture with a lender, HSBC UK Bank Plc, which contains a fixed charge over certain assets and floating charge over all property and undertaking of the Company, present or future in relation to amounts owed by the Company or any other group companies. The existing Composite Guarantee and Debenture with Arbuthnot Commercial Asset Based Lending Limited and Debenture with Lloyds Bank Plc, were released at the same time. The Company also entered into a charge with HSBC Invoice Finance (UK) Limited which contains a fixed charge over certain assets and a floating charge over certain present and future assets in relation to amounts owed by the Company. Page 14
SUI GENERIS INTERNATIONAL LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
13. | Controlling party
The parent company is Sui Generis Holdings Limited by virtue of it’s 100% shareholding. The registered office is Lindsey House, Brunel Way, Severalls Industrial Park, Colchester, Essex, CO4 9QX. Milbank Ventures Limited is the parent company of the largest and smallest group for which consolidated accounts are prepared. Its registered office, from which group accounts can be requested, is Lindsey House, Brunel Way, Severalls Industrial Park, Colchester, Essex, CO4 9QX.
14. | Auditors' information
The auditors' report on the financial statements for the year ended 31 December 2024 was qualified. The qualification in the audit report was as follows: We were not appointed as auditors of the company until after the year ended 31 December 2023 and thus did not sufficiently observe the counting of stock at that date. We were unable to satisfy ourselves by alternative means concerning the stock quantities held at 31 December 2023, which were included in the opening balance sheet at £731,722, by using other audit procedures. We were also unable to gain sufficient evidence over the amount and timing of accrued income recognised at 31 December 2023 totalling £156,132. Consequently, we were unable to determine whether any adjustment to opening stock or accrued income were necessary. The audit report was signed on 18 September 2025 by Barry Gostling (Senior statutory auditor) on behalf of Ensors.
Page 15